Quick Answer
Fresenius Medical Care AG reported R&D Expense of $157.97 million for fiscal year 2025.
Fresenius Medical Care AG R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $157.97M | -13.9% |
| 2024 | $183.49M | -20.9% |
| 2023 | $231.97M | +1.5% |
| 2022 | $228.62M | +3.6% |
| 2021 | $220.78M | +13.9% |
| 2020 | $193.77M | +15.3% |
| 2019 | $168.03M | +47.3% |
| 2018 | $114.07M | +2.8% |
| 2017 | $111.00M | -24.2% |
| 2016 | $146.51M | +14.3% |
| 2015 | $128.13M | +4.9% |
| 2014 | $122.11M | -2.9% |
| 2013 | $125.81M | +12.7% |
| 2012 | $111.63M | +0.7% |
| 2011 | $110.83M | +14.8% |
| 2010 | $96.53M | +2.9% |
| 2009 | $93.81M | +16.9% |
| 2008 | $80.24M | +20.6% |
| 2007 | $66.52M | — |
- Fresenius Medical Care AG showed a decrease of -13.9% in R&D Expense compared to the prior fiscal year.
- Over the 2007–2025 period, Fresenius Medical Care AG’s r&d expense has grown by 137.5% (from $66.52 million to $157.97 million).
- The most recent figure is from Fresenius Medical Care AG’s fiscal year 2025 report (Form 20-F), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: